Formulation design and evaluation of aceclofenac nanogel for topical application

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

• 1. Allen KD, Golightly YM. State of the evidence. Curr. Opin. Rheumatol. 27(3), 276–283 (2015).
  MedlineGoogle Scholar
• 2. Mccurry SM, Von Korff M, Vitiello MV et al. Frequency of comorbid insomnia, pain, and depression in older adults with osteoarthritis: predictors of enrollment in a randomized treatment trial. J. Psychosom. Res. 71(5), 296–299 (2011).
  MedlineGoogle Scholar
• 3. Maniar KH, Jones IA, Gopalakrishna R, Vangsness CT Jr. Lowering side effects of NSAID usage in osteoarthritis: recent attempts at minimizing dosage. Expert Opin. Pharmacother. 19(2), 93–102 (2018).
  Medline CASGoogle Scholar
• 4. Crofford LJ. Use of NSAIDs in treating patients with arthritis. Arthritis Res. Ther. 15(Suppl. 3), S2 (2013).
  MedlineGoogle Scholar
• 5. Rannou F, Pelletier JP, Martel-Pelletier J. Efficacy and safety of topical NSAIDs in the management of osteoarthritis: evidence from real-life setting trials and surveys. Semin. Arthritis Rheum. 45(Suppl. 4), S18–S21 (2016). • Efficacy and safety of nonsteroidal anti-inflammatory drugs.
  Medline CASGoogle Scholar
• 6. Pelletier JP, Martel-Pelletier J, Rannou F, Cooper C. Efficacy and safety of oral NSAIDs and analgesics in the management of osteoarthritis: evidence from real-life setting trials and surveys. Semin. Arthritis Rheum. 45(Suppl. 4), S22–S27 (2016).
  Medline CASGoogle Scholar
• 7. Thakur S, Riyaz B, Patil A, Kaur A, Kapoor B, Mishra V. Novel drug delivery systems for NSAIDs in management of rheumatoid arthritis: an overview. Biomed. Pharmacother. 106, 1011–1023 (2018).
  Medline CASGoogle Scholar
• 8. Lee J, Lee Y, Kim J, Yoon M, Choi YW. Formulation of microemulsion systems for transdermal delivery of aceclofenac. Arch. Pharm. Res. 28(9), 1097–1102 (2005).
  Medline CASGoogle Scholar
• 9. Nasr M, Mansour S, Mortada ND, Elshamy AA. Vesicular aceclofenac systems: a comparative study between liposomes and niosomes. J. Microencapsul. 25(7), 499–512 (2008).
  Medline CASGoogle Scholar
• 10. Dasgupta S, Dey S, Choudhury S, Mazumder B. Topical delivery of aceclofenac as nanoemulsion comprising excipients having optimum emulsification capabilities: preparation, characterization and in vivo evaluation. Expert Opin. Drug Deliv. 10(4), 411–420 (2013).
  Medline CASGoogle Scholar
• 11. Dasgupta S, Ghosh SK, Ray S, Mazumder B. Solid lipid nanoparticles (SLNs) gels for topical delivery of aceclofenac in vitro and in vivo evaluation. Curr. Drug Deliv. 10(6), 656–666 (2013).
  Medline CASGoogle Scholar
• 12. Nasr M, Mansour S, Mortada ND, El Shamy AA. Lipospheres as carriers for topical delivery of aceclofenac: preparation, characterization and in vivo evaluation. AAPS Pharm. Sci. Tech. 9(1), 154–162 (2008).
  Medline CASGoogle Scholar
• 13. Algahtani MS, Ahmad MZ, Ahmad J. Nanoemulsion loaded polymeric hydrogel for topical delivery of curcumin in psoriasis. J. Drug Deliv. Sci. Technol. 59, 101847 (2020).
  CASGoogle Scholar
• 14. Khurana B, Arora D, Narang RK. FbD supported development and in vitro evaluation of carbomer based resveratrol loaded topical antipsoriatic nanoemulgel for its targeted skin delivery. Pharm.Nanotechnol. 8(2), 91–107 (2020).
  Medline CASGoogle Scholar
• 15. Arora D, Nanda S. Quality by design driven development of resveratrol loaded ethosomal hydrogel for improved dermatological benefits via enhanced skin permeation and retention. Int. J. Pharm. 567, 118448 (2019).
  Medline CASGoogle Scholar
• 16. Shafiq-Un-Nabi S, Shakeel F, Talegaonkar S et al. Formulation development and optimization using nanoemulsion technique: a technical note. AAPS Pharm. Sci. Tech. 8(2), E12–E28 (2007). •• Low energy method for the preparation of nanoemulsion (NE).
  MedlineGoogle Scholar
• 17. Ahmad J, Kohli K, Mir SR, Amin S. Formulation of self-nanoemulsifying drug delivery system for telmisartan with improved dissolution and oral bioavailability. J. Dispers. Sci. Technol. 32(7), 958–968 (2011).
  CASGoogle Scholar
• 18. Algahtani MS, Ahmad MZ, Ahmad J. Nanoemulgel for improved topical delivery of retinyl palmitate: formulation design and stability evaluation. Nanomaterials (Basel, Switzerland) 10(5), E848 (2020).
  Medline CASGoogle Scholar
• 19. Gupta SK. Formulation and evaluation of nanoemulsion based nanoemulgel of aceclofenac. J. Pharm. Sci. Res. 12(4), 524–532 (2020).
  Google Scholar
• 20. Modi JD, Patel JK. Nanoemulsion-based gel formulation of aceclofenac for topical delivery. Int. J. Sci. Res. Methodol. 1(1), 6–12 (2011).
  Google Scholar
• 21. Kotta S, Khan AW, Ansari SH, Sharma RK, Ali J. Formulation of nanoemulsion: a comparison between phase inversion composition method and high-pressure homogenization method. Drug Deliv. 22(4), 455–466 (2015). •• Comparative study of phase inversion composition method and high-pressure homogenization method for NE formulation.
  Medline CASGoogle Scholar
• 22. Izquierdo P, Feng J, Esquena J et al. The influence of surfactant mixing ratio on nano-emulsion formation by the pit method. J. Colloid Interface Sci. 285(1), 388–394 (2005).
  Medline CASGoogle Scholar
• 23. Jafari SM, He Y, Bhandari B. Optimization of nano-emulsions production by microfluidization. Eur. Food Res. Technol. 225(5-6), 733–741 (2007).
  CASGoogle Scholar
• 24. Akhter S, Anwar M, Siddiqui MA et al. Improving the topical ocular pharmacokinetics of an immunosuppressant agent with mucoadhesive nanoemulsions: formulation development, in-vitro and in-vivo studies. Colloids Surf. B Biointerfaces 148, 19–29 (2016).
  Medline CASGoogle Scholar
• 25. Algahtani MS, Ahmad MZ, Nourein IH, Ahmad J. Co-delivery of imiquimod and curcumin by nanoemugel for improved topical delivery and reduced psoriasis-like skin lesions. Biomolecules 10(7), 968 (2020). •• NE delivery system for co-delivery of two drugs.
  Medline CASGoogle Scholar
• 26. Ahmad J, Gautam A, Komath S, Bano M, Garg A, Jain K. Topical nano-emulgel for skin disorders: formulation approach and characterization. Recent Pat. Antiinfect Drug Discov. 14(1), 36–48 (2019).
  Medline CASGoogle Scholar
• 27. Alam S, Algahtani MS, Ahmad MZ, Ahmad J. Investigation utilizing the HLB concept for the development of moisturizing cream and lotion: in-vitro characterization and stability evaluation. Cosmetics 7(2), 43 (2020). •• Utilization of HLB cocept and RHLB.
  CASGoogle Scholar
• 28. Hajjar B, Zier K-I, Khalid N, Azarmi S, Löbenberg R. Evaluation of a microemulsion-based gel formulation for topical drug delivery of diclofenac sodium. Int. J. Pharm. Investig. 48(3), 351–362 (2018).
  CASGoogle Scholar
• 29. Md S, Alhakamy NA, Aldawsari HM et al. Improved analgesic and anti-inflammatory effect of diclofenac sodium by topical nanoemulgel: formulation development-in vitro and in vivo studies. J.Chem. 2020, (2020).
  Google Scholar
• 30. Shakeel F, Baboota S, Ahuja A, Ali J, Aqil M, Shafiq S. Nanoemulsions as vehicles for transdermal delivery of aceclofenac. AAPS Pharm. Sci. Tech. 8(4), E104 (2007).
  MedlineGoogle Scholar
• 31. Ahmad J, Mir SR, Kohli K et al. Solid-nanoemulsion preconcentrate for oral delivery of paclitaxel: formulation design, biodistribution, and γ scintigraphy imaging. Biomed. Res. Int. 2014, 984756 (2014).
  MedlineGoogle Scholar
• 32. Yuan Y, Gao Y, Zhao J, Mao L. Characterization and stability evaluation of β-carotene nanoemulsions prepared by high pressure homogenization under various emulsifying conditions. Food Res. Int. 41(1), 61–68 (2008).
  CASGoogle Scholar
• 33. Gupta A, Eral HB, Hatton TA, Doyle PS. Nanoemulsions: formation, properties and applications. Soft Matter 12(11), 2826–2841 (2016).
  Medline CASGoogle Scholar
• 34. Mao L, Xu D, Yang J, Yuan F, Gao Y, Zhao J. Effects of small and large molecule emulsifiers on the characteristics of β-carotene nanoemulsions prepared by high pressure homogenization. Food Technol. Biotechnol. 47(3), 336–342 (2009).
  CASGoogle Scholar
• 35. Qian C, Mcclements DJ. Formation of nanoemulsions stabilized by model food-grade emulsifiers using high-pressure homogenization: factors affecting particle size. Food Hydrocoll. 25(5), 1000–1008 (2011).
  CASGoogle Scholar
• 36. Azeem A, Rizwan M, Ahmad FJ, Khar RK, Iqbal Z, Talegaonkar S. Components screening and influence of surfactant and cosurfactant on nanoemulsion formation. Curr. Nanosci. 5(2), 220–226 (2009).
  CASGoogle Scholar
• 37. Khurana B, Arora D, Narang R. Topical delivery of nanoemulsion for antipsoriatic drugs. J. Drug Deliv. Ther. 8(5-s), 1–11 (2018).
  CASGoogle Scholar
• 38. Baspinar Y, Keck CM, Borchert HH. Development of a positively charged prednicarbate nanoemulsion. Int. J. Pharm. 383(1-2), 201–208 (2010).
  Medline CASGoogle Scholar
• 39. Mustafa G, Baboota S, Ali J et al. Effect of homogenization on the fate of true nanoemulsion in brain translocation: a gamma scintigraphic evaluation. Sci. Adv. Materials 4(7), 739–748 (2012).
  CASGoogle Scholar
• 40. Marie P, Perrier-Cornet J, Gervais P. Influence of major parameters in emulsification mechanisms using a high-pressure jet. J. Food Eng. 53(1), 43–51 (2002).
  Google Scholar
• 41. Kumar M, Bishnoi RS, Shukla AK, Jain CP. Techniques for formulation of nanoemulsion drug delivery system: a review. Prev. Nutr. Food Sci. 24(3), 225–234 (2019).
  Medline CASGoogle Scholar
• 42. Sobhani H, Tarighi P, Ostad SN, Shafaati A, Nafissi-Varcheh N, Aboofazeli R. Formulation development and toxicity assessment of triacetin mediated nanoemulsions as novel delivery systems for rapamycin. Iran. J. Pharm. Res. 14(Suppl.), 3–21 (2015).
  Medline CASGoogle Scholar
• 43. Bali V, Ali M, Ali J. Nanocarrier for the enhanced bioavailability of a cardiovascular agent: in vitro, pharmacodynamic, pharmacokinetic and stability assessment. Int. J. Pharm. 403(1-2), 46–56 (2011).
  Medline CASGoogle Scholar
• 44. Khurana S, Jain NK, Bedi PM. Nanoemulsion based gel for transdermal delivery of meloxicam: physico-chemical, mechanistic investigation. Life Sci. 92(6-7), 383–392 (2013).
  Medline CASGoogle Scholar
• 45. Rai VK, Mishra N, Yadav KS, Yadav NP. Nanoemulsion as pharmaceutical carrier for dermal and transdermal drug delivery: formulation development, stability issues, basic considerations and applications. J. Control. Rel. 270, 203–225 (2018).
  Medline CASGoogle Scholar
• 46. Sinko PJ, Singh Y. Martin's physical pharmacy and pharmaceutical sciences: physical chemical and biopharmaceutical principles in the pharmaceutical sciences. Walter Kluer (2011).
  Google Scholar
• 47. Lee CH, Moturi V, Lee Y. Thixotropic property in pharmaceutical formulations. J. Control. Rel. 136(2), 88–98 (2009).
  Medline CASGoogle Scholar
• 48. Mastropietro DJ, Nimroozi R, Omidian H. Rheology in pharmaceutical formulations – a perspective. J. Dev. Drugs 2(2), 1–6 (2013).
  Google Scholar
• 49. Owen DH, Peters JJ, Katz DF. Rheological properties of contraceptive gels. Contraception 62(6), 321–326 (2000).
  Medline CASGoogle Scholar
• 50. Chen MX, Alexander KS, Baki G. Formulation and evaluation of antibacterial creams and gels containing metal ions for topical application. J Pharm. 2016, 5754349 (2016).
  MedlineGoogle Scholar
• 51. Neupane R, Boddu SHS, Renukuntla J, Babu RJ, Tiwari AK. Alternatives to biological skin in permeation studies: current trends and possibilities. Pharmaceutics 12(2), (2020).
  MedlineGoogle Scholar